Renin-angiotensin system expression in the K562 human erythroleukaemic cell line

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 8, Issue 3, 2007, Pages 145-147

  Koca, Ebru ^a   Haznedaroglu, Ibrahim C ^a   Acar, Kudir ^b   Beyazit, Yavuz ^a   Aksu, Salih ^a   Misirlioglu, Muge ^c   Tuncer, Serdar ^c   Sayinalp, Nilgun ^a   Ozcebe, Osman I ^a   Uner, Aysegul ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^c Metis Biotechnology Ltd   (Turkey)

Author keywords

ACE; Angiotensinogen; Cell line; K562 human erythroleukaemia; Renin; Renin angiotensin system

Indexed keywords

ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE; MESSENGER RNA; RENIN;

ARTICLE; CANCER CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; ERYTHROCYTE; ERYTHROLEUKEMIA CELL; GRANULOCYTE; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA; LEUKEMIA CELL; MONOCYTE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STEM CELL;

ANGIOTENSINOGEN; CELL LINE; COMPUTER SYSTEMS; HUMANS; LEUKEMIA, ERYTHROBLASTIC, ACUTE; PEPTIDYL-DIPEPTIDASE A; POLYMERASE CHAIN REACTION; RENIN; RENIN-ANGIOTENSIN SYSTEM; RNA, MESSENGER;

EID: 36348999857     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.3317/jraas.2007.019     Document Type: Article

References (15)

1. Abali H, Haznedaroglu IC, Goker H et al. Circulating and local bone marrow renin-angiotensin system in leukaemic haematopoiesis: preliminary evidences. Haematology 2002;7:75-82.
2. Hajek D, Tomiska M, Krahulcova E et al. I/D ACE gene polymorphism in survival of leukaemia patients - hypothesis and pilot study. Med Hypotheses 2003;61:80-5.
3. Beyazit Y, Aksu S, Haznedaroglu IC et al. Overexpression of the local bone marrow renin-angiotensin system in acute myeloid leukaemia. J Natl Med Assoc 2007;99:57-63.
4. Haznedaroglu IC, Ozturk MA. Towards the understanding of the local haematopoietic bone marrow renin-angiotensin system. Int J Biochem Cell Biol 2003;35:867-80.
5. Bernstein KE. Views of the renin-angiotensin system: brilling, mimsy, and slithy tove. Hypertension 2006;47:509-14.
6. Hubert C, Savary K, Gasc JM, Corvol P. The hematopoietic system: a new niche for the renin-angiotensin system. Nat Clin Pract Cardiovasc Med 2006;3:80-5.
7. Aksu S, Beyazit Y, Haznedaroglu IC et al. Over-expression of angiotensin-converting enzyme (CD 143) on leukemic blasts as a clue for the activated local bone marrow RAS in AML. Leuk Lymphoma 2006; 47:891-6.
8. Pinto RP, Wang KK, Khoury H, Schimmer AD, Minden MD. Aberrant Expression of Angiotensin in Acute Myeloid Leukemia Blood 2004; 102:2124A.
9. Marusic-Vrsalovic M, Dominis M, Jaksic B, Kusec R. Angiotensin I-converting enzyme is expressed by erythropoietic cells of normal and myeloproliferative bone marrow. Br J Haematol 2003; 123:539-41.
10. Teresa Gomez CM, del I, Perera M et al. Renin expression in haematological malignancies and its role in the regulation of haematopoiesis. Leuk Lymphoma 2002;43:2377-81.
11. Blasius R, Reuter S, Henry E, Dicato M, Diederich M. Curcumin regulates signal transducer and activator of transcription (STAT) expression in K562 cells. Biochem Pharmacol 2006;72:1547-54.
12. Menon J, Soto-Pantoja DR, Callahan MF et al. Angiotensin-(1-7) Inhibits Growth of Human Lung Adenocarcinoma Xenografts in Nude Mice through a Reduction in Cyclooxygenase-2. Cancer Res 2007; 67:2809-15.
13. Akalin I, Koca E, Karabulut HG et al. Angiotensin Converting Enzyme (ACE) Insertion/Deletion (I/D) Gene Polymorphisms in Leukaemic Haematopoiesis. Eur J Hum Genet 2007;15(suppl 1):161.
14. Abali H, Gullu IH, Engin H, Haznedaroglu IC, Erman M, Tekuzman G. Old antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists. Med Hypotheses 2002;59:344-8.
15. Caires AC, Oliveira CR, Smith MC, Hemerly JP, Juliano MA, Bincoletto C. Effects of palladacycle complex on haematopoietic progenitor cells proliferation in vivo and in vitro and its relation with the inhibitory properties of this compound on the angiotensin-I converting enzyme activity. Immunopharmacol Immunotoxicol 2004; 26:487-500.